Last reviewed · How we verify
Homologated placebo.
Homologated placebo. is a Small molecule drug developed by Instituto Mexicano del Seguro Social. It is currently in Phase 3 development. Also known as: no other intervention.
A homologated placebo is an inert control substance formulated to match the appearance, taste, and physical properties of an active investigational drug for blinded clinical trial purposes.
At a glance
| Generic name | Homologated placebo. |
|---|---|
| Also known as | no other intervention |
| Sponsor | Instituto Mexicano del Seguro Social |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Homologated placebos are specially prepared inactive formulations used in Phase 3 randomized controlled trials to maintain blinding and reduce bias. They contain no active pharmaceutical ingredient but are manufactured to be indistinguishable from the active comparator in terms of organoleptic properties, packaging, and administration route, ensuring that neither patients nor investigators can identify treatment assignment.
Approved indications
Common side effects
Key clinical trials
- Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes. (PHASE2)
- Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (PHASE2)
- Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (PHASE2)
- Dexamethasone and Respiratory Function After Mastectomy (PHASE3)
- Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (PHASE2)
- Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes (PHASE2)
- Atorvastatin in the Recipient's Kidney Graft From a Living Donor (PHASE3)
- Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Homologated placebo. CI brief — competitive landscape report
- Homologated placebo. updates RSS · CI watch RSS
- Instituto Mexicano del Seguro Social portfolio CI
Frequently asked questions about Homologated placebo.
What is Homologated placebo.?
How does Homologated placebo. work?
Who makes Homologated placebo.?
Is Homologated placebo. also known as anything else?
What development phase is Homologated placebo. in?
Related
- Manufacturer: Instituto Mexicano del Seguro Social — full pipeline
- Also known as: no other intervention
- Compare: Homologated placebo. vs similar drugs
- Pricing: Homologated placebo. cost, discount & access